Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model

scientific article published on February 1993

Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.37.2.234
P932PMC publication ID187645
P698PubMed publication ID8452353
P5875ResearchGate publication ID14747664

P2093author name stringQuintiliani R
Nightingale CH
Lawlor MT
Cooper BW
Sullivan MC
P2860cites workThe postantibiotic effect: a review of in vitro and in vivo dataQ33617455
Ciprofloxacin in acute exacerbations of chronic bronchitisQ34180747
Pharmacokinetics of ciprofloxacin after oral and parenteral administrationQ35570646
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteersQ35640637
Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in miceQ36753658
Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobialsQ37901918
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Q39651339
The mode of action of 4-quinolones and possible mechanisms of resistanceQ39754868
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistanceQ39828366
Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro modelQ39833928
Effect of dose size on bioavailability of ciprofloxacinQ40283886
Nalidixic Acid: an Antibacterial ParadoxQ40944835
Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumoniaQ42106566
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitisQ42203654
Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacinQ42226724
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal modelQ43617611
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal modelQ43932771
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic modelQ44090962
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentrationQ44483617
Inappropriate use of oral ciprofloxacinQ45070443
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.Q51634358
Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.Q54408341
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.Q54765685
The post-antimicrobial suppressive effect of quinolone agents.Q54770044
Evidence for a Slow Elimination Phase for Penicillin GQ68438201
The postantibiotic effectQ69011396
Kinetics of antimicrobial activityQ69494182
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporinsQ69572281
In vivo postantibiotic effect in a thigh infection in neutropenic miceQ70370760
Postantibiotic suppression of bacterial growthQ71543981
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectStreptococcus pneumoniaeQ221179
P304page(s)234-239
P577publication date1993-02-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleEvaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model
P478volume37

Reverse Query: null

Search more.